Literature DB >> 32058423

Letter to the Editor: Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial.

Saubhik Das1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32058423      PMCID： PMC7282573          DOI： 10.1097/CORR.0000000000001163

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.755


× No keyword cloud information.
  12 in total

1.  The safest and most efficacious route of tranexamic acid administration in total joint arthroplasty: A systematic review and network meta-analysis.

Authors:  Sheng Xu; Jerry Yongqiang Chen; Qishi Zheng; Ngai Nung Lo; Shi-Lu Chia; Keng Jin Darren Tay; Hee Nee Pang; Luming Shi; Edwin Shih Yen Chan; Seng Jin Yeo
Journal:  Thromb Res       Date:  2019-02-11       Impact factor: 3.944

2.  The Efficacy of Tranexamic Acid in Total Knee Arthroplasty: A Network Meta-Analysis.

Authors:  Yale A Fillingham; Dipak B Ramkumar; David S Jevsevar; Adolph J Yates; Peter Shores; Kyle Mullen; Stefano A Bini; Henry D Clarke; Emil Schemitsch; Rebecca L Johnson; Stavros G Memtsoudis; Siraj A Sayeed; Alexander P Sah; Craig J Della Valle
Journal:  J Arthroplasty       Date:  2018-05-05       Impact factor: 4.757

3.  Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.

Authors:  Rajesh N Maniar; Gaurav Kumar; Tushar Singhi; Ravi Mohan Nayak; Parul R Maniar
Journal:  Clin Orthop Relat Res       Date:  2012-03-15       Impact factor: 4.176

4.  Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Christian Skovgaard Nielsen; Øivind Jans; Thue Ørsnes; Nicolai Bang Foss; Anders Troelsen; Henrik Husted
Journal:  J Bone Joint Surg Am       Date:  2016-05-18       Impact factor: 5.284

5.  Intravenous vs Topical Tranexamic Acid in Total Knee Arthroplasty Without Tourniquet Application: A Randomized Controlled Study.

Authors:  Themistoklis K Tzatzairis; Georgios I Drosos; Stamatios E Kotsios; Athanasios N Ververidis; Theodosia D Vogiatzaki; Konstantinos I Kazakos
Journal:  J Arthroplasty       Date:  2016-05-11       Impact factor: 4.757

6.  Most Effective Regimen of Tranexamic Acid for Reducing Bleeding and Transfusions in Primary Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Wen-Li Dai; Ai-Guo Zhou; Hua Zhang; Jian Zhang
Journal:  J Knee Surg       Date:  2017-09-11       Impact factor: 2.757

7.  Combined Administration of Systemic and Topical Tranexamic Acid for Total Knee Arthroplasty: Can It Be a Better Regimen and Yet Safe? A Randomized Controlled Trial.

Authors:  Nimesh P Jain; Prithviraj P Nisthane; Nilen A Shah
Journal:  J Arthroplasty       Date:  2015-09-26       Impact factor: 4.757

8.  The Safety of Tranexamic Acid in Total Joint Arthroplasty: A Direct Meta-Analysis.

Authors:  Yale A Fillingham; Dipak B Ramkumar; David S Jevsevar; Adolph J Yates; Peter Shores; Kyle Mullen; Stefano A Bini; Henry D Clarke; Emil Schemitsch; Rebecca L Johnson; Stavros G Memtsoudis; Siraj A Sayeed; Alexander P Sah; Craig J Della Valle
Journal:  J Arthroplasty       Date:  2018-03-22       Impact factor: 4.757

9.  Comparison of intravenous, topical or combined routes of tranexamic acid administration in patients undergoing total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.

Authors:  Qi Sun; Jinyu Li; Jiang Chen; Chenying Zheng; Chuyin Liu; Yusong Jia
Journal:  BMJ Open       Date:  2019-01-28       Impact factor: 2.692

10.  Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial.

Authors:  Prashant Meshram; Jeya Venkatesh Palanisamy; Jong Yeon Seo; Jong Geun Lee; Tae Kyun Kim
Journal:  Clin Orthop Relat Res       Date:  2020-01       Impact factor: 4.755
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.